Skip to Content

  • Search

View Additional Section Content

A PHASE II TRIAL OF TRAMETINIB WITH DOCETAXEL IN PATIENTS WITH KRAS MUTATION POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) AND PROGRESSIVE DISEASE FOLLOWING ONE OR TWO PRIOR SYSTEMIC THERAPIES

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02642042?term=s1507&rank=1

Clinical Trial Categories

  • Lung Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details